Boostrix (Tdap) Interactions
There are 304 drugs known to interact with Boostrix (Tdap) (diphtheria toxoid/pertussis, acellular/tetanus toxoid), along with 4 disease interactions. Of the total drug interactions, 1 is major, 300 are moderate, and 3 are minor.
- View all 304 medications that may interact with Boostrix (Tdap)
- View Boostrix (Tdap) disease interactions (4)
Most frequently checked interactions
View interaction reports for Boostrix (Tdap) (diphtheria toxoid / pertussis, acellular / tetanus toxoid) and the medicines listed below.
- acetaminophen
- albuterol
- allopurinol
- amlodipine
- amoxicillin
- atorvastatin
- benzonatate
- cephalexin
- clindamycin
- clonazepam
- doxycycline
- duloxetine
- gabapentin
- ibuprofen
- lisinopril
- melatonin
- metformin
- Metoprolol Succinate ER (metoprolol)
- Moderna COVID-19 Vaccine (COVID-19 mRNA (Moderna) vaccine)
- omeprazole
- ondansetron
- pantoprazole
- prednisone
- Shingrix (zoster vaccine, recombinant)
- tizanidine
- Tylenol Extra Strength (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- vitamin e
Boostrix (Tdap) disease interactions
There are 4 disease interactions with Boostrix (Tdap) (diphtheria toxoid / pertussis, acellular / tetanus toxoid) which include:
Report options
QR code containing a link to this page
More about Boostrix (Tdap) (diphtheria toxoid / pertussis, acellular / tetanus toxoid)
- Boostrix (Tdap) consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: vaccine combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.